Ideaya Biosciences Profit Margin

Ideaya Biosciences (IDYA) currently reports a profit margin of -1149.62% as of September 2026. That compares with -74.46% in the prior-year period — down 1444.0% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Ideaya Biosciences's profit margin history and peer comparisons.

Ideaya Biosciences's profit margin decreased from -74.46% to -1149.62% — a 1444.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ideaya Biosciences's profit margin of -1149.62% is lower than the Healthcare sector average of 19.13%. That is roughly 6109.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ideaya Biosciences's current -1149.62% should be judged against Healthcare norms (sector average: 19.13%) and against IDYA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1149.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Ideaya Biosciences, and consider following IDYA for alerts when major investors trade the stock.